Search

everythinglearnresearchcommunity

for

Search:↓

A breast cancer patient had lasting hair loss after chemotherapy, which improved with minoxidil treatment.

CEP135 may predict cancer outcomes, and targeting PLK1 could help treat certain sarcomas.

Men with frontal male pattern baldness may have a higher risk of gastric cancer.

Taking 5-alpha reductase inhibitors does not increase the risk of breast cancer in men.

Genetic differences within ethnic groups may affect prostate cancer treatment effectiveness.

The number of advanced breast cancer cases in women under 40 has increased, but the overall numbers are still low.

Older ovarian cancer patients live longer and tolerate weekly chemotherapy better than three-weekly treatments.

Eating more omega-3 and less omega-6 fatty acids may lower the risk of developing prostate cancer.

Different prostate cancer treatments have similar risks of secondary cancers and related mortality when considering patient age and smoking history.

ROR-alpha may increase the growth of certain breast cancer cells by boosting aromatase, which could affect breast cancer prognosis.

Dutasteride may lower the chance of finding prostate cancer in men with enlarged prostates.

New compounds were found to help increase hair growth and decrease hair loss.

Micrografts improve hair density and thickness without side effects.

Using finasteride or dutasteride does not increase the risk of male breast cancer.

The surgery effectively promoted and maintained weight loss in obese women during the first year.

JAK inhibitors effectively regrow hair in alopecia areata but hair loss often returns after stopping treatment.

The moisturizing cream used after a chemical peel was well tolerated and effectively moisturized the skin.

Applying the anti-cancer drug Bortezomib to skin can promote hair growth and increase hair proteins through the GATA-3 factor.

New treatments are making advanced prostate cancer management more complex but also more hopeful.

Blood tests for tumor cells could improve prostate cancer diagnosis and treatment; hair loss severity linked to a gene affecting prostate conditions.

Incidental prostate cancer was found in 4.89% of patients undergoing surgery for benign prostatic hyperplasia.

Alopecia can often be managed effectively with various treatments, but early diagnosis is crucial for preventing permanent hair loss.

Men, especially older ones with health issues like prostate cancer, may have worse COVID-19 outcomes and could benefit from therapies targeting male hormones.

Androgen Deprivation Therapy for prostate cancer often reduces sexual function but intermittent therapy may be more tolerable.

Most treatments for hair loss in 1997 were not effective for most people, and maintaining hair growth was difficult.

Baldness in men with prostate cancer is linked to higher levels of certain sex hormones, but chest hair density is not.

Cancer treatments can cause skin-related side effects that may affect patient quality of life and require changes in treatment.

Young women in West Bengal, India, with PCOS often have estrogen resistance, leptin receptor issues, folate deficiency, T2DM, and acanthosis, commonly linked to obesity.

Hair loss is a common, often overlooked side effect of hormone treatments for breast and prostate cancer.

Patients with metabolic syndrome had lower Gleason scores when diagnosed with prostate cancer.